NCT06598293 Routine Electronic Patient-reported Outcome Measures During and After Radiotherapy: A Randomized Controlled Study
| NCT ID | NCT06598293 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yonsei University |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 536 participants |
| Start Date | 2024-09-03 |
| Primary Completion | 2027-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 536 participants in total. It began in 2024-09-03 with a primary completion date of 2027-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients in this study will be asked to periodically self-report their symptoms using their smartphones during the radiotherapy period and during the acute phase (3 months) after treatment, and radiation oncology physicians will evaluate the impact on cancer patients' quality of life and determine whether they can improve health outcomes by using this data in their practice.
Eligibility Criteria
Inclusion Criteria: * Age \> 18 * Histologically confirmed diagnosis of cancer * Eastern Cooperative Oncology Group (ECOG) 0 or 1 * The ability to own and use a smartphone Exclusion Criteria: * Terminal cancer * Cognitive impairment * Not using your smartphone
Contact & Investigator
Hwakyung BYUN, Phd
PRINCIPAL INVESTIGATOR
Severance Hospital
Frequently Asked Questions
Who can join the NCT06598293 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06598293 currently recruiting?
Yes, NCT06598293 is actively recruiting participants. Contact the research team at hkbyun05@yuhs.ac for enrollment information.
Where is the NCT06598293 trial being conducted?
This trial is being conducted at Yongin-si, South Korea.
Who is sponsoring the NCT06598293 clinical trial?
NCT06598293 is sponsored by Yonsei University. The principal investigator is Hwakyung BYUN, Phd at Severance Hospital. The trial plans to enroll 536 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.